Cencora's trading volume on March 6th was $406 million, a decrease of 32.96% compared to the previous trading day.

On March 6, 2026, the health care products distributor Cencora (COR) had a trading volume of $406 million, ranking 330th among U.S. stocks that day, a decrease of 32.96% from yesterday, with a trading volume of 1.1358 million.

Cencora (COR) fell 0.23% on March 6, 2026, closing at $358.46. The stock has decreased 3.68% over the past 5 trading days, and the entire March has declined 3.68%. Since the beginning of the year, it has risen 6.13%, and over the past 52 weeks, it has increased 41.25%.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to now (the same applies to cases where the listing duration is less than 1 month or fewer than 5 trading days).

Cencora released its Q1 FY2026 earnings report on February 4, 2026. From October 1, 2025, to December 31, 2025, revenue was $786.2k, a year-over-year increase of 5.45%, with a net profit of $566 million, up 14.67% year-over-year.

Cencora, Inc. is one of the world’s largest pharmaceutical procurement and distribution service companies, helping healthcare providers as well as pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care opportunities. The company offers innovative programs and services aimed at increasing the efficiency and effectiveness of the drug supply chain in human and animal health. Specifically, the company provides comprehensive brands, specialty brands, and non-patented drugs, over-the-counter medical products, home healthcare supplies and equipment, and related services to various healthcare providers in the U.S. and some global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order pharmacies, clinics, long-term care and alternative site pharmacies, physician practices, medical and dialysis clinics, veterinarians, and other clients. Additionally, the company offers a range of related services for healthcare providers and pharmaceutical manufacturers, including data analytics, outcomes research, reimbursement and drug consulting services, niche premium logistics, inventory management, pharmacy automation, pharmacy management, and packaging solutions.